Effects of hypoxic cell radiosensitizer doranidazole (PR-350) on the radioresponse of murine and human tumor cells in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/16210793

Download in:

View as

General Info

PMID
16210793